Effect of H2S in treatment of ibs

Synthetizing gelatin capsule containing H2S+Peppermint for treating patients with Irritable Bowel Syndrome

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180127038518N1

Enrollment

Registered

2018-07-18

Start date

2018-05-22

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome. Irritable bowel syndrome

Interventions

Intervention 1: Intervention group: Patients receive 5 mg Capsule BID. Intervention 2: Control group: Placebo group. Intervention 3: Intervention group: receive capsule at dose 5 mg/day. Intervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The inclusion criteria are: any patients with IBS ( Having the ROME criteria 4) and not having any laboratories or clinical and/or colonoscopy problems

Exclusion criteria

Exclusion criteria: The exclusion criteria are those patients without IBS.Existing any problems in laboratories-, clinical-, or colonoscopy reports

Design outcomes

Primary

Measure	Time frame
The frequency of Diarrhea. Timepoint: on a daily basis for two months. Method of measurement: Measuring the defecation.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactPejman Alavinejad

Ahvaz University of Medical Sciences

pezhmanalavinejad@gmail.com+98 61 3221 6104

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026